Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

Abstract Background and objective Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. Methods We retrospectively ex...

Full description

Bibliographic Details
Main Authors: Kodai Kawamura, Kazuya Ichikado, Hidenori Ichiyasu, Keisuke Anan, Yuko Yasuda, Moritaka Suga, Takuro Sakagami
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Pulmonary Medicine
Subjects:
IPF
Antifibrotic agent
Corticosteroids
Chronic fibrotic interstitial pneumonia
Proton pump inhibitor
Online Access:http://link.springer.com/article/10.1186/s12890-019-0880-0

Internet

http://link.springer.com/article/10.1186/s12890-019-0880-0

Similar Items